Stockreport

Lexaria Begins Dosing of Its Second GLP-1 Human Pilot Study [Yahoo! Finance]

Lexaria Bioscience Corp.  (LEXX) 
PDF drug delivery platforms announces that human pilot study #2, GLP-1-H24-2, (the "Study") is underway and the first dosing visit for all nine study participants has alread [Read more]